Osteoporosis Rx Poor Within 6 Months of Hip Fracture

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The key factors predicting stable response to tralokinumab every 4 weeks (vs every 2 weeks) were IGA 0/1 and EASI-75, according to a small post hoc analysis.

Keith A. Reynolds

October 1st 2024

RSVPreF Reduces Risk of Severe RSV in Older, High-Risk Adults in Large Real-World Study

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

RSVPreF Vaccine Reduces Risk of Severe RSV in Older, High-Risk Adults in Large Real-World Study / image credit©auremar/stock.adobe.com

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The new research augments data on efficacy of RSVPreF in older, high-risk adults that was not captured in phase 3 pivotal clinical trials, authors said.

October 25th 2023

Zyn Nicotine Pouches Get FDA Nod But Not Without Warnings

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Zyn nicotine pouches get FDA nod for sale but not without caveats / image credit ©Natalia/stock.adobe.com

Elinzanetant Found Safe, Effective for VMS Linked to Breast Cancer Treatment: Daily Dose

Agency review determined the pouches to be less harmful to health than cigarettes and an aid to smoking cessation but did not declare the products "safe."

Tralokinumab Dosing Every 4 Weeks is Effective Maintenance Regimen for Atopic Dermatitis, Study Suggests

Your daily dose of the clinical news you may have missed.

Related Content

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The key factors predicting stable response to tralokinumab every 4 weeks (vs every 2 weeks) were IGA 0/1 and EASI-75, according to a small post hoc analysis.

Keith A. Reynolds

October 1st 2024

RSVPreF Reduces Risk of Severe RSV in Older, High-Risk Adults in Large Real-World Study

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The new research augments data on efficacy of RSVPreF in older, high-risk adults that was not captured in phase 3 pivotal clinical trials, authors said.

October 25th 2023

Zyn Nicotine Pouches Get FDA Nod But Not Without Warnings

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Elinzanetant Found Safe, Effective for VMS Linked to Breast Cancer Treatment: Daily Dose

Agency review determined the pouches to be less harmful to health than cigarettes and an aid to smoking cessation but did not declare the products "safe."